AI-generated summary
The authors reviewed the National Clinical Trial database and PubMed to summarize photobiomodulation therapy for age-related macular degeneration and diabetic retinopathy. They extracted fourteen AMD studies and nine diabetic macular edema studies and report that patients in some subgroups showed response to treatment. The authors note notable methodological differences between studies and call for larger, higher-powered studies.
- Who or what was studied
- Patients with age-related macular degeneration or diabetic retinopathy, including diabetic macular edema
- Limits stated in the abstract
- The abstract notes notable methodological differences between studies, the need for high-powered studies with standard devices and timing, and that major clinical trial results are still pending.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Age-related macular degeneration, Photobiomodulation therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.